Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial Carcinoma.
Séverine BanekMike WenzelBenedikt LauerQuynh Chi LeBenedikt HoehFlorestan KollCristina Cano GarciaClara HumkeJens KöllermannFelix K H ChunMarina KosibaLuis A KluthPublished in: Urologia internationalis (2024)
AVM is associated with moderate AE rates. Despite similarities in baseline characteristics compared to trial-selected JAVELIN Bladder 100 mUC patients, AVM resulted in longer/similar PFS but significantly shorter OS in real-world setting.